Bramasta Nugraha

Bramasta (Bram) Nugraha, MBA, PhD, currently serves as a Senior Scientist in Stem Cell Biology at Novo Nordisk, focusing on the establishment and scalable manufacture of clinical-grade kidney organoids for cell therapy applications while also contributing to the Chronic Heart Failure pipeline. With extensive experience in research and mentorship, Bram functions as an external Ph.D. mentor at Karolinska Institutet, a reviewer for Nature Communications Biology, and an editor for MDPI publications. Previous roles include Associate Principal Scientist at AstraZeneca, where contributions spanned several drug discovery projects, and Senior Scientist at the University of Zurich, focusing on organoid models. Bram holds multiple advanced degrees, including a Ph.D. in Bioengineering and Biomedical Engineering from the National University of Singapore, in addition to an Executive MBA from Quantic School of Business and Technology.